Metastatic prostate cancer with a normal prostate-specific antigen level
Clin. transl. oncol. (Print)
; 7(9): 412-413, oct. 2005. ilus
Article
in En
| IBECS
| ID: ibc-040798
Responsible library:
ES1.1
Localization: ES1.1 - BNCS
RESUMEN
Prostate-specific antigen (PSA) is the most commonly used tumour marker for prostate cancer, both in screening and in follow-up. However, there are many false positive increases in the presence of other prostate diseases and, currently, there is no consensus regarding sensitivity and specificity of the PSA test, nor what constitutes the upper limit of normality. We report a case of a 67-year-old patient with metastatic prostate cancer who, with increased level of alkaline phosphatase and normal PSA, showed clinical and radiological evidence of progression of the disease
Search on Google
Collection:
National databases
/
Spain
Database:
IBECS
Main subject:
Prostatic Neoplasms
/
Prostate-Specific Antigen
Type of study:
Diagnostic study
Limits:
Aged
/
Humans
/
Male
Language:
English
Journal:
Clin. transl. oncol. (Print)
Year:
2005
Document type:
Article
Institution/Affiliation country:
Hospital Universitario de Salamanca/España